На этой странице перечислены больницы направления «Дерматология» (включая Breast Reconstruction with Implant) в Дубай, ОАЭ, включая Burjeel Hospital for Advanced Surgery Dubai, Kings College Hospital Dubai, Aster Hospital Dubai.
Спросите нас о «Breast Reconstruction with Implant» в Дубай, ОАЭ
Оставьте свои данные — наша команда координации свяжется с вами и расскажет о следующих шагах.
Сравните 3 аккредитованных больниц (Дерматология) в Дубай, ОАЭ
Рекомендуем🇦🇪 Burjeel Hospital for Advanced Surgery Dubai
Больница занимает 1-е место в этом списке по указанному рейтингу (4.5/5, 1 отзывов).
🇦🇪 Kings College Hospital Dubai
Больница занимает 2-е место в этом списке по указанному рейтингу (4.5/5, 1 отзывов).
🇦🇪 Aster Hospital Dubai
Больница занимает 3-е место в этом списке по указанному рейтингу (4.5/5, 1 отзывов).
Как мы выбираем эти больницы
Больница появляется на этой странице, если направление «Дерматология» указано среди её специализаций и она находится в Дубай, ОАЭ. Сортировка — по указанному рейтингу (по убыванию), без редакционного рейтинга «лучших».
Как выбрать лучшую больницу для «breast reconstruction with implant» в Дубай, ОАЭ?
Выбор подходящей больницы для «breast reconstruction with implant» — важное решение в вашем пути лечения. Вот на что стоит обратить внимание:
Международная аккредитация
Ищите больницу с международной аккредитацией, например JCI или NABH — см. отметки аккредитации у каждой больницы ниже.
Специализация
Убедитесь, что в больнице есть отделение, специализирующееся на «Дерматология», а не только общая помощь.
Мощность и опыт
Количество коек и год основания, указанные ниже, отражают масштаб и операционный опыт больницы.
Прозрачность стоимости
Запросите детализированную смету перед поездкой — используйте наш калькулятор стоимости для первичной оценки.
Что нужно знать о процедуре «Breast Reconstruction with Implant»
Breast reconstruction with implant is a restorative plastic surgery procedure that rebuilds the breast mound following mastectomy or significant tissue loss, using silicone or saline prostheses — often in combination with tissue expanders — achieving high patient satisfaction rates exceeding 85% in high-volume centres. International patients increasingly choose India and the UAE for this procedure, benefiting from world-class oncoplastic surgical expertise, state-of-the-art implant technology, and dramatically reduced costs without compromising clinical outcomes. GAF Healthcare connects patients to JCI- and NABH-accredited hospitals in India and JCI- and DHA-licensed facilities in Dubai and Abu Dhabi, managing every step from initial consultation to post-operative follow-up. Hospital Stay: 3–5 days (implant-only); 5–7 days (tissue expander + implant two-stage protocol) • Total Stay in Country (Fit-to-Fly): 3–5 weeks (short-haul); 5–6 weeks (long-haul intercontinental flights, compression garment mandatory) • Success Rate: 85–92% patient satisfaction; implant survival rate >95% at 10 years with modern cohesive gel devices
Clinical Overview
Breast reconstruction with implant is a subspecialty of oncoplastic and reconstructive surgery designed to restore breast volume, contour, and symmetry after total or skin-sparing mastectomy — whether performed prophylactically, for breast cancer treatment, or following traumatic tissue loss. The procedure addresses the profound physiological and psychosocial sequelae of mastectomy: disruption of chest wall soft-tissue architecture, loss of inframammary fold definition, altered thoracic proprioception, and the well-documented impact on body image and quality of life measured on validated instruments such as the BREAST-Q questionnaire. Modern implant reconstruction achieves near-normal breast aesthetics by exploiting the skin-sparing or nipple-sparing mastectomy envelope as a biological scaffold for prosthetic volume replacement. The standard of care has evolved considerably over the past decade. The traditional two-stage protocol — in which a tissue expander is placed at the time of mastectomy and subsequently exchanged for a permanent silicone implant at 3–6 months — remains the most widely used approach globally, offering the surgeon iterative control over final volume and projection. However, direct-to-implant (DTI) single-stage reconstruction, now routinely enabled by acellular dermal matrices (ADMs) such as AlloDerm, Braxon, or DermACELL, is increasingly offered to carefully selected patients with adequate native skin flaps and favourable tumour staging, eliminating a second general anaesthetic. The advent of form-stable, highly cohesive gel ('gummy bear') implants, pre-pectoral placement planes, and biologic mesh integration has substantially reduced the historical complications of animation deformity and upper-pole distortion seen with traditional sub-pectoral positioning. Leading reconstructive surgeons in India and the UAE are trained in full oncoplastic fellowship curricula and routinely perform both implant-based and autologous (DIEP flap, latissimus dorsi flap) reconstruction, allowing a genuinely patient-centred choice of modality. Facilities utilise intraoperative tools including indocyanine green (ICG) angiography (SPY imaging system) to map mastectomy flap perfusion in real time, dramatically reducing ischaemic complications and implant loss — a technology standard at GAF Healthcare's partner hospitals.
Who is a Candidate?
• IDEAL CANDIDATES: • Women who have undergone or are planning total mastectomy (therapeutic or risk-reducing/prophylactic) for breast cancer (Stage I–III) or BRCA1/BRCA2 pathogenic variant carriers • Patients with adequate mastectomy skin flap thickness and viability confirmed by ICG perfusion mapping • Adequate body habitus: BMI ≤ 35 kg/m²; morbid obesity (BMI > 40) significantly increases complication risk • Non-smokers, or patients who have ceased smoking for a minimum of 6 weeks prior to surgery (nicotine quantified by urinary cotinine assay) • Patients who have completed neoadjuvant chemotherapy with ≥ 4 weeks' washout and haematological recovery (ANC > 1.5 × 10⁹/L; platelets > 100 × 10⁹/L) • Patients who do NOT require immediate post-mastectomy radiotherapy (PMRT) or where radiation is deferred — active PMRT is a relative contraindication to primary implant placement due to 3–4× higher capsular contracture and implant loss rates • REQUIRED PRE-OPERATIVE DIAGNOSTICS: • Bilateral mammogram and breast MRI (gadolinium-enhanced) or PET-CT (18F-FDG) to confirm disease staging and contralateral breast status • Echocardiogram (ECHO) and 12-lead ECG if prior anthracycline (doxorubicin, epirubicin) chemotherapy (cardiotoxicity screening) • Full blood count, coagulation profile (PT/INR/aPTT), HbA1c (diabetes screening), liver and renal function panel • Nutritional assessment: serum albumin, pre-albumin (hypoalbuminaemia <3.5 g/dL associated with impaired wound healing) • Anaesthetic fitness: ASA Physical Status classification; cardiopulmonary exercise testing (CPET) for high-risk patients • Genetic counselling and BRCA panel result review (relevant for prophylactic reconstruction decisions) • CONTRAINDICATIONS: • Active local or systemic infection • Uncontrolled diabetes (HbA1c > 8.5%) — defer until optimised • Active smoking within 6 weeks of surgery • Prior chest wall radiation without adequate soft-tissue coverage (consider latissimus dorsi or DIEP flap instead) • Known allergy or hypersensitivity to silicone (extremely rare; patch-test and allergen panel required) • Active autoimmune connective tissue disease (e.g., scleroderma) — relative contraindication; multidisciplinary rheumatology review mandatory • Metastatic (Stage IV) disease where systemic prognosis limits reconstruction benefit (case-by-case oncological MDT decision)
Treatment Options & Approaches
STAGE 1: TISSUE EXPANDER-BASED TWO-STAGE RECONSTRUCTION (MOST COMMON) At the time of mastectomy, a textured or smooth saline-filled tissue expander (e.g., Mentor CPX4, Allergan Natrelle 133) is placed in the sub-pectoral or pre-pectoral plane, partially inflated, and supported inferolaterally with an acellular dermal matrix (ADM) sling. Over 3–6 months of outpatient expansion (30–60 mL saline added every 2–3 weeks via a transcutaneous port), the skin envelope is gradually stretched to target volume. At Stage 2 (day-surgery or 1-night admission), the expander is removed and exchanged for a permanent cohesive silicone gel implant, with simultaneous refinements to the inframammary fold and symmetry procedures on the contralateral breast if indicated. STAGE 2: DIRECT-TO-IMPLANT (DTI) SINGLE-STAGE RECONSTRUCTION Enabled by real-time ICG perfusion angiography (SPY Elite/SPY PHI system), DTI places a permanent implant immediately after mastectomy in a single operative episode. ADM (AlloDerm, Braxon pre-pectoral matrix) creates a complete implant pocket, eliminating the need for muscular coverage. Ideal for skin-sparing or nipple-sparing mastectomy patients with DIEP-unfavourable anatomy, DTI reduces total treatment time by 3–6 months and avoids a second general anaesthetic. Contraindicated when mastectomy flap perfusion is compromised on ICG imaging. PRE-PECTORAL vs. SUB-PECTORAL PLANE Pre-pectoral placement (implant anterior to pectoralis major, supported entirely by ADM) eliminates the animation deformity (implant displacement with pectoralis contraction) characteristic of sub-pectoral reconstruction, preserves pectoralis muscle function, reduces post-operative pain, and shortens recovery. It requires robust ADM support and high-quality skin flaps. Sub-pectoral ('dual-plane') placement remains preferred when skin flaps are thin, poorly perfused, or post-irradiated. IMPLANT SELECTION • Form-stable highly cohesive silicone gel ('gummy bear') implants: anatomical (teardrop) or round profiles; 5th-generation devices (Motiva Ergonomix, Mentor MemoryShape, Allergan Natrelle 410) with progressive gel cohesivity. Lower bleed rate, shape retention on rupture, and superior upper-pole aesthetics compared to older generation devices. • Smooth vs. macro-textured vs. nanotextured surfaces: following global regulatory reviews on BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma) linked to macro-textured/polyurethane devices, most GAF partner centres now use smooth or nanotextured (SilkSurface, Motiva) implants with significantly lower BIA-ALCL risk profiles. • Saline implants: less commonly used in reconstruction; useful when MRI surveillance for rupture is prioritised. NIPPLE-AREOLA COMPLEX (NAC) RECONSTRUCTION Performed as a tertiary procedure 3–4 months after final implant exchange: local flap techniques (skate flap, C-V flap, star flap) reconstruct the nipple projection; medical tattooing by specialist paramedical tattoo artists recreates areola pigmentation. Some centres offer 3D areola tattooing as an outpatient alternative to surgical NAC reconstruction. FAT GRAFTING (LIPOFILLING / STRUCTURAL FAT TRANSFER) Autologous fat harvested by low-pressure liposuction (Coleman technique) is processed and micro-injected to correct contour irregularities, rippling, and upper-pole hollowing around the implant. Typically performed as an adjunct 6–12 months post-reconstruction. Multiple sessions may be required. ROBOTIC AND ENDOSCOPIC-ASSISTED APPROACHES A small number of GAF partner centres offer robot-assisted (da Vinci platform) or endoscopic axillary-approach reconstruction for select nipple-sparing mastectomy cases, minimising visible chest wall scarring — particularly valued by patients of South and East Asian heritage with keloid tendency.
Восстановление
PRE-OPERATIVE PHASE (4–8 WEEKS BEFORE SURGERY) • Step 1 — Virtual Consultation: Upload medical records, pathology reports, operative notes, and imaging to GAF Healthcare's secure patient portal. A GAF case manager schedules a video consultation with a reconstructive surgeon within 48 hours. • Step 2 — Medical Clearance: Complete the required diagnostic workup (ECHO, PET-CT or MRI, blood panel, HbA1c, coagulation profile) either at home or upon arrival at the destination hospital. Anaesthetic pre-assessment conducted. • Step 3 — Implant and Technique Selection: 3D breast imaging (Vectra XT volumetric simulation) used in partner centres to model expected outcomes across implant sizes and profiles. Surgical plan documented and consented. • Step 4 — Pre-operative Optimisation: Smoking cessation confirmed (urinary cotinine test), nutritional supplementation (Vitamin C, zinc, high-protein diet), cessation of anticoagulants/NSAIDs/herbal supplements 10–14 days pre-op. HbA1c optimised to < 7.5% in diabetic patients. • Step 5 — Arrival & Admission: GAF Healthcare coordinates airport pickup, hotel or hospital accommodation for patient and attendant. Pre-operative skin chlorhexidine wash protocol initiated 48 hours before surgery. INTRA-OPERATIVE PHASE • Step 6 — Anaesthesia: General anaesthesia with enhanced recovery after surgery (ERAS) protocol: total intravenous anaesthesia (TIVA) preferred to reduce post-operative nausea; multimodal regional anaesthesia (pectoralis nerve block — PECS I/II block) for opioid-sparing analgesia. • Step 7 — Procedure: Duration 2–4 hours (single-stage DTI) or 3–5 hours (two-stage with simultaneous expander placement at mastectomy). ICG perfusion angiography performed intraoperatively to assess flap viability before implant placement. ADM secured and implant/expander positioned. Closed-suction drains (Jackson-Pratt) placed. • Step 8 — Immediate Post-operative: Patient monitored in recovery room and high-dependency unit for first 12–24 hours. Intravenous antibiotics (cephalosporin class), DVT prophylaxis (LMWH — enoxaparin), and compression stockings initiated. INPATIENT RECOVERY (DAYS 1–5) • Step 9 — Days 1–2: Drains output monitored (< 30 mL/24 h = threshold for removal). Gradual mobilisation with physiotherapy. Oral analgesia escalated (paracetamol + ibuprofen + gabapentin multimodal regimen; opioids minimised). Wound inspected daily. • Step 10 — Days 3–5: Drains removed when output criteria met. Supportive surgical bra fitted. Patient discharged with written drain and wound care instructions. EARLY OUTPATIENT RECOVERY (WEEKS 1–4) • Step 11 — Week 1–2: Suture removal or wound review at GAF partner clinic on post-op day 10–14. Arm elevation restricted (no overhead lifting > 0.5 kg). Sleep in semi-reclined position. Scar management with silicone gel strips initiated from week 2. • Step 12 — Week 3–4: Gradual return to light activities of daily living. Walking encouraged. No driving for 4 weeks. First expander inflation appointment at week 3–4 (if two-stage protocol). • Step 13 — Fit-to-Fly Assessment: GAF medical team conducts clinical review at week 4–5. Fitness for international travel confirmed when: drains removed, wounds healed, no haematoma/seroma, DVT risk assessed (CAPRINI score). Compression garment and LMWH prophylaxis prescribed for long-haul flights (>4 hours). LONG-TERM MILESTONES • 6 weeks: Return to low-impact exercise (walking, stationary cycling) • 3 months: Return to full gym activities; Stage 2 implant exchange planning begins (two-stage patients) • 6 months: Fat grafting adjunct procedures if required; nipple reconstruction planning • 12 months: Final aesthetic assessment; contralateral symmetry procedure if desired; BREAST-Q outcome scoring • Annual: MRI surveillance (non-contrast for silicone integrity assessment; recommended every 5–6 years per FDA 2021 guidance, or annually post-radiation)
Возможные риски
Breast reconstruction with implant carries procedure-specific risks that every patient must understand prior to informed consent. Early complications (within 30 days) include haematoma formation (1–3%), seroma accumulation requiring aspiration (5–10% in expander-based cases), surgical site infection (2–4%, higher in diabetic or immunosuppressed patients), and mastectomy flap necrosis (1–5%) — the most critical early risk, as full-thickness skin loss may necessitate implant removal. Implant-specific long-term risks include capsular contracture (Baker Grade III–IV requiring revision surgery) occurring in 10–20% of cases over 10 years, particularly following post-mastectomy radiotherapy where rates rise to 30–40%; implant rupture or gel bleed (approximately 1% per year with modern 5th-generation devices, detected by MRI); implant malposition or rotation (more prevalent with anatomical/teardrop implants); and rippling or visibility (more common in thin patients with pre-pectoral placement). Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a rare T-cell lymphoma historically linked to macro-textured implant surfaces, with a cumulative risk estimated at 1 in 2,000–86,000 implant recipients depending on device type; GAF partner centres exclusively use smooth or nanotextured devices with substantially lower BIA-ALCL risk profiles. Breast Implant Illness (BII) — a patient-reported syndrome of systemic symptoms attributed to implants — lacks a confirmed immunological mechanism but is acknowledged by regulatory bodies; patients with pre-existing autoimmune conditions require detailed counselling. Anaesthetic risks are mitigated by rigorous ECHO and cardiopulmonary screening, particularly relevant for patients with prior anthracycline exposure. Thromboembolic events (DVT, pulmonary embolism) are reduced by LMWH prophylaxis and early ambulation. Patients are advised that revision surgery rates over a 10-year horizon approach 20–25%, encompassing capsulorrhaphy, fat grafting, implant exchange, and symmetry procedures — costs for which should be factored into long-term financial planning.
Почему GAF Healthcare
GAF Healthcare provides end-to-end non-medical coordination for international patients travelling to India or the UAE for breast reconstruction with implant, ensuring clinical focus remains undivided throughout the journey. INDIA: • e-Medical Visa: GAF Healthcare's visa assistance team prepares and submits the complete e-Medical Visa application (supported for 150+ nationalities via the Indian government's online portal), including hospital admission letters, surgeon credentials, and estimated duration of stay. Processing typically takes 3–5 business days. Multi-entry e-Medical Visas allow re-entry for the Stage 2 implant exchange procedure if the patient returns home between stages. • Accreditation Assurance: All partner hospitals in India hold NABH (National Accreditation Board for Hospitals) and/or JCI (Joint Commission International) accreditation, meeting global patient safety benchmarks. • Ground Logistics: Private air-conditioned airport transfers to hospital or partner serviced apartment. Dedicated patient concierge available 24/7 via WhatsApp. • Translation: Certified medical interpreters available in Arabic, Russian, French, Swahili, Bangla, and 12 additional languages for all clinical consultations and consent processes. • Attendant Accommodation: GAF Healthcare pre-negotiates discounted rates at hotels adjacent to or within the hospital campus (typically $40–80 USD/night), with meal delivery arrangements for the accompanying family member or caregiver. UAE (DUBAI / ABU DHABI): • Visa Access: Citizens of 50+ countries (EU, UK, USA, GCC nationals, and many Commonwealth nations) receive visa-free entry or a visa-on-arrival for 30–90 days — ideal for the typical 4–6 week treatment and recovery stay. GAF Healthcare confirms entry requirements for each patient's nationality in advance and assists with any required prior-entry visa applications. • Accreditation Assurance: UAE partner facilities hold JCI accreditation and are fully licensed by the Dubai Health Authority (DHA) or Abu Dhabi Department of Health (DoH), with consultant surgeons holding internationally recognised FRCS(Plast) or American Board of Plastic Surgery (ABPS) credentials. • Ground Logistics: Luxury private transfers from Dubai International or Abu Dhabi International airports. Concierge services including same-day SIM card provisioning, currency exchange, and pharmacy liaison. • Translation: Arabic, Farsi, Hindi, Russian, and French medical interpretation available as standard. English is the primary clinical language at all UAE partner centres. • Attendant Accommodation: GAF Healthcare coordinates serviced apartment bookings within 5–10 minutes of partner hospitals, with options ranging from $80–200 USD/night depending on proximity and amenity level. Patient families requiring halal dietary catering or prayer facility access are accommodated as standard. TELEMEDICINE FOLLOW-UP: All patients receive a structured remote follow-up schedule post-discharge — video consultations at 2 weeks, 6 weeks, 3 months, and 6 months — with wound imaging reviewed by the operating surgeon via the GAF Healthcare secure platform. Any urgent concerns trigger a 24-hour clinical response protocol.
Частые вопросы о процедуре «Breast Reconstruction with Implant»
What is the cost of breast reconstruction with implant in India vs. the UAE?
How long do I need to stay in the country before I am fit to fly home after breast reconstruction with implant?
What is the success rate of breast reconstruction with implant, and what does it mean for my outcome?
Похожие страницы
Как GAF Healthcare помогает выбрать лучшую больницу для «breast reconstruction with implant» в Дубай, ОАЭ
Найдите лучшие больницы для «breast reconstruction with implant» в Дубай, ОАЭ
На этой странице представлено 3 больниц в Дубай, ОАЭ, чтобы вы могли сравнить аккредитацию и специализации в одном месте.
Поддержка, когда она нужна
Отправьте нам свои медицинские отчёты в WhatsApp или по email — наша медицинская команда изучит их и предложит больницу и план лечения.
Прозрачные, всё включено цены
Мы предоставляем единую детализированную смету, покрывающую расходы больницы и проживание — без скрытых платежей.
Организация визы, поездки и проживания
После выбора больницы мы помогаем оформить визовое приглашение, забронировать проживание рядом с больницей и организовать трансфер.
Хотите узнать примерную стоимость лечения? Используйте наш калькулятор стоимости для персональной оценки.
Частые вопросы о «Breast Reconstruction with Implant» в Дубай, ОАЭ
Сколько больниц направления «Дерматология» представлено в Дубай, ОАЭ?
Как вы выбираете больницы для списка?
Сколько стоит лечение в Дубай, ОАЭ?
Следующий шаг
Отправьте нам свои медицинские отчёты — наша команда предложит больницу и план лечения для «Breast Reconstruction with Implant» в Дубай, ОАЭ.
Свяжитесь с нами, если заметите неточность на этой странице.